Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ETERNA-THERAPEUTICS-INC-120380178/news/Lineage-Enters-into-Option-and-License-Agreement-with-Eterna-Therapeutics-to-Develop-Hypoimmune-Plur-43064201/?utm_source=whatsapp&utm_medium=social&utm_campaign=share